?
Can we develop Nrf2 activators with improved CNS penetration?
active
open question
Created: 2026-04-25T20:29:32
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-394cc839-019b-4593-ad5b-a2
Open Question
open
Wiki: proteins-keap1-protein
Can we develop Nrf2 activators with improved CNS penetration?
Importance Elo
1500
Field Rank
Rank #445 in proteins
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page proteins-keap1-protein
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
Blood-Brain Barrier SPM Shuttle System
candidate answer · hypothesis · 82%
s:**
- Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engineered vs native antibodies
- Test whether pH-modified variants retain microglia
discriminating experiment · experiment · 78%
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation
discriminating experiment · hypothesis · 76%
s:**
- Compare uptake with/without magnetic particles using tight junction integrity markers
- Test whether clustering occurs at BBB-relevant TfR expr
bears on question · experiment · 58%
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
bears on question · hypothesis · 55%
s:**
- Dose-response studies showing therapeutic window without toxicity
- Cell-type specific effects across CNS populations
- Demonstration that enha
bears on question · experiment · 52%
Nrf2 inhibitor ML385 mechanism validation experiment
bears on question · experiment · 45%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
hypothesis | bears_on_question
Blood-Brain Barrier SPM Shuttle System
hypothesis | candidate_answer
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation
hypothesis | discriminating_experiment
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:32.518158'} |
| field_tag | proteins |
| source_id | proteins-keap1-protein |
| sub_field | keap1-protein |
| source_kind | wiki |
| question_hash | af6e93278ceff6816d86ebbf6c571dd2f0b26219d3215d92468da6ba782323cb |
| question_text | Can we develop Nrf2 activators with improved CNS penetration? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page proteins-keap1-protein |
| evidence_xref_at | 2026-04-27T13:58:25.308726+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
8
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.